Proursan 250mg Capsules, Hard Ireland - English - HPRA (Health Products Regulatory Authority)

proursan 250mg capsules, hard

pro.med.cs praha a.s. - ursodeoxycholic acid - capsule, hard - 250 milligram(s) - bile acid preparations; ursodeoxycholic acid

Proursan 400 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

proursan 400 mg film-coated tablets

pro.med.cs praha a.s. - ursodeoxycholic acid - film-coated tablet - 400 milligram(s) - ursodeoxycholic acid

Proursan 500 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

proursan 500 mg film-coated tablets

pro.med.cs praha a.s. - ursodeoxycholic acid - film-coated tablet - 500 milligram(s) - bile acid preparations; ursodeoxycholic acid

REFLAD 50 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

reflad 50 mg film-coated tablets

pro.med.cs praha a.s. - itopride hydrochloride - film-coated tablet - itopride

Levodropropizine ELC 30mg/5ml Syrup Malta - English - Medicines Authority

levodropropizine elc 30mg/5ml syrup

elc group s.r.o. pobrezni 394/12, karlin 186 00 prague 8, czech republic - levodropropizine - syrup - levodropropizine 30 ml/5ml - cough and cold preparations

Quemed 10 mg Tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

quemed 10 mg tablets

pharmeng technology sdn. bhd. - solifenacin succinate -

Quemed 5 mg Tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

quemed 5 mg tablets

pharmeng technology sdn. bhd. - solifenacin succinate -

Progit 50mg Tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

progit 50mg tablets

pharmeng technology sdn. bhd. - itopride hydrochloride -

Ursosan 250 mg Hard Capsules Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ursosan 250 mg hard capsules

pharmeng technology sdn. bhd. - ursodeoxycholic acid -

CEPROTIN protein c 1000IU powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

ceprotin protein c 1000iu powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - protein c, quantity: 1000 iu - injection, intravenous infusion - excipient ingredients: water for injections - ceprotin is indicated in purpura fulminas and coumarin induced skin necrosis in patients with severe congenital protein c deficiency. since safety and efficacy data are not available in conditions other than severe congenital deficiency, use should be limited to these conditions.